Shuttle Pharmaceuticals Holdings, Inc. (SHPH) analyses
1 analysis in the last 30 days. Latest: .
Market Scanner’s AI analysis of Shuttle Pharmaceuticals Holdings, Inc. (SHPH), updated July 2026: Shuttle Pharmaceuticals Holdings' recent coverage focused on its stock's significant intraday gains amidst mixed market signals and technical indicators.
Summary
Shuttle Pharmaceuticals Holdings' recent coverage focused on its stock's significant intraday gains amidst mixed market signals and technical indicators.
Recent analyses examined Shuttle Pharmaceuticals Holdings' (SHPH.US) stock performance, noting its inclusion among top midday and premarket gainers with double-digit after-hours gains. The reports also covered technical indicators such as SMAs, EMAs, RSI, MFI, and MACD, which presented a mixed picture of momentum and overbought conditions. Fundamental data highlighted the company's market capitalization, P/E ratio, and negative profit margins.
Factors discussed — upside
- Included in 'Top Midday Gainers' and 'Top Premarket Gainers'
- Reported double-digit gains after market hours
- Money Flow Index (MFI) in overbought territory (87.21)
Factors discussed — risks
- Trading below 50-day and 200-day SMAs
- 10-day EMA below 50-day SMA
- MACD suggesting bearish momentum (-0.4682)
- Profit Margin and Operating Margin (TTM) at 0%
- Return on Equity (TTM) at -3.26355%
- Technical Indicators
- Stock Performance
- Fundamental Data
- Market Context
Summary updated .
Analyses
Recent SHPH.US analyses are locked — sign in to read them or generate a fresh one.
Frequently asked questions
- What is the bull case for Shuttle Pharmaceuticals Holdings, Inc.?
- Recent AI analyses of Shuttle Pharmaceuticals Holdings, Inc. discussed upside factors including Included in 'Top Midday Gainers' and 'Top Premarket Gainers', reported double-digit gains after market hours, and money Flow Index (MFI) in overbought territory (87.21).
- What are the risks for Shuttle Pharmaceuticals Holdings, Inc.?
- Recent AI analyses of Shuttle Pharmaceuticals Holdings, Inc. flagged risks including Trading below 50-day and 200-day SMAs, 10-day EMA below 50-day SMA, MACD suggesting bearish momentum (-0.4682), profit Margin and Operating Margin (TTM) at 0%, and return on Equity (TTM) at -3.26355%.
- Is Shuttle Pharmaceuticals Holdings, Inc. bullish or bearish?
- Recent AI analyses of Shuttle Pharmaceuticals Holdings, Inc. examined factors on both sides. Discussed upside: Included in 'Top Midday Gainers' and 'Top Premarket Gainers', reported double-digit gains after market hours, and money Flow Index (MFI) in overbought territory (87.21). Discussed risks: Trading below 50-day and 200-day SMAs, 10-day EMA below 50-day SMA, MACD suggesting bearish momentum (-0.4682), profit Margin and Operating Margin (TTM) at 0%, and return on Equity (TTM) at -3.26355%. These are descriptive observations, not a recommendation.
- What is the latest sentiment on Shuttle Pharmaceuticals Holdings, Inc.?
- Recent analyses examined Shuttle Pharmaceuticals Holdings' (SHPH.US) stock performance, noting its inclusion among top midday and premarket gainers with double-digit after-hours gains. The reports also covered technical indicators such as SMAs, EMAs, RSI, MFI, and MACD, which presented a mixed picture of momentum and overbought conditions. Fundamental data highlighted the company's market capitalization, P/E ratio, and negative profit margins.
- Bundles used
- gemini-low-v2
Sign in to read every SHPH.US report in the library
Each analysis includes the full reasoning, dissent, and decision rationale from the structured AI pipeline.
Sign in to see full analyses